Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

7.0K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

211
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
211
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

168
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
168
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

193
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
193
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

195
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
195
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

4.8K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment-refractory hypothyroidism: Don't just increase the dose.

Cleveland Clinic journal of medicine·2026
Same author

Subclinical hypothyroidism: What's in a name?

Cleveland Clinic journal of medicine·2025
Same author

Users of chronic prescription opioids decrease in the first 12 months following bariatric surgery.

Obesity (Silver Spring, Md.)·2024
Same author

Exploring the Link Between Thyrotoxicosis and Cognitive Decline in Older Adults-Reply.

JAMA internal medicine·2024
Same author

Endogenous and Exogenous Thyrotoxicosis and Risk of Incident Cognitive Disorders in Older Adults.

JAMA internal medicine·2023
Same author

Levothyroxine Dosing in Older Adults: Recommendations Derived From The Baltimore Longitudinal Study of Aging.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2023

Related Experiment Video

Updated: Jan 5, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.4K

Interpreting Elevated TSH in Older Adults.

Jennifer S Mammen1

  • 1Johns Hopkins School of Medicine, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism.

Current Opinion in Endocrine and Metabolic Research
|October 22, 2019
PubMed
Summary

Thyroid stimulating hormone (TSH) testing in older adults may lead to over-treatment of subclinical hypothyroidism. Current guidelines may be inappropriate, suggesting a need for new diagnostic tools for targeted thyroid therapy.

More Related Videos

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

1.2K
Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
07:40

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

7.7K

Related Experiment Videos

Last Updated: Jan 5, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.4K
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

1.2K
Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
07:40

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

7.7K

Area of Science:

  • Endocrinology
  • Geriatric Medicine
  • Clinical Chemistry

Background:

  • Thyroid function is typically monitored using thyrotropin (TSH) levels.
  • Subclinical hypothyroidism is defined by elevated TSH with normal thyroid hormone levels.
  • Elevated TSH is prevalent in older adults, often leading to overtreatment with levothyroxine.

Purpose of the Study:

  • To question the current diagnostic algorithm for subclinical hypothyroidism in older adults.
  • To highlight the lack of demonstrated harm from not treating and lack of benefit from treating mild TSH elevations in this population.
  • To advocate for new clinical tools that consider age-related pathophysiology for targeted thyroid therapy.

Main Methods:

  • Review of existing clinical observations and treatment outcomes.
  • Analysis of the limitations of current diagnostic criteria for subclinical hypothyroidism in the elderly.
  • Exploration of age-related variability in thyroid function test pathophysiology.

Main Results:

  • Observations suggest no harm from withholding treatment and no benefit from treating mild TSH elevations in older adults.
  • The standard diagnostic algorithm based solely on TSH may be inappropriate for this demographic.
  • Age-specific reference ranges alone do not address underlying disease definitions.

Conclusions:

  • The current approach to diagnosing and treating subclinical hypothyroidism in older adults requires re-evaluation.
  • Relying on population norms via age-specific ranges may not be sufficient.
  • New diagnostic strategies are needed to ensure levothyroxine therapy is used only when truly beneficial.